APA (7th ed.) Citation

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment & ProQuest (Firm). (1994). Orphan drug reauthorization: Hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Third Congress, second session on H.R. 4160, a bill to amend the Federal Food, Drug, and Cosmetic Act, the Public Health Service Act, and the Orphan Drug Act to revise the provisions of such acts relating to orphan drugs, June 16, 1994. U.S. G.P.O..

Chicago Style (17th ed.) Citation

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment and ProQuest (Firm). Orphan Drug Reauthorization: Hearing Before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Third Congress, Second Session on H.R. 4160, a Bill to Amend the Federal Food, Drug, and Cosmetic Act, the Public Health Service Act, and the Orphan Drug Act to Revise the Provisions of Such Acts Relating to Orphan Drugs, June 16, 1994. Washington: U.S. G.P.O., 1994.

MLA (9th ed.) Citation

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment and ProQuest (Firm). Orphan Drug Reauthorization: Hearing Before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Third Congress, Second Session on H.R. 4160, a Bill to Amend the Federal Food, Drug, and Cosmetic Act, the Public Health Service Act, and the Orphan Drug Act to Revise the Provisions of Such Acts Relating to Orphan Drugs, June 16, 1994. U.S. G.P.O., 1994.